Along with the Knight Cancer Institute at Oregon Health & Science University (OSHU), Intel has launched Collaborative Cancer Cloud (CCC), a service designed to enable providers and researchers to securely share genomic, imaging and clinical data among patients.

The collaborative plans, by 2020, to have physicians be able to give a patient a diagnosis and generate a specific treatment plan within 24 hours. Over time, the platform will be modified to support other types of research and treatment, according to a release.

CCC has conducted initial technical connecting of servers with OHSU as well as two other unidentified facilities in Austin and Boston.

The collaborative cloud "ties together top cancer institutions across the world to share data and advance scientific discovery. The cloud provides access to technology and services (analytics platforms and tools) that dramatically increase the speed, precision and cost-effectiveness of analyzing a patient's individual genetic profile. New big data technologies across a number of Intel's ecosystem partners are making this vision a reality in a way that can become mainstream across large numbers of hospitals and research institutions," according to information on Intel's website.

General availability of the Collaborative Cancer Cloud is expected in the first quarter of 2016 with no cost to join other than an organization’s costs for putting the infrastructure in place.